Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Carbohydrate digestion enzymes" are a collective term for enzymes that catalyze the hydrolysis of dietary carbohydrates into monosaccharides, which can be absorbed in the intestine. The primary enzymes involved include salivary amylase and pancreatic amylase (which break down starches into oligosaccharides and maltose), and brush border disaccharidases such as maltase, sucrase, and lactase (which cleave disaccharides into glucose, fructose, and galactose)[1][2][3][9]. These enzymes are produced by the salivary glands, pancreas, and intestinal epithelial cells. Therapeutic inhibitors (e.g., acarbose, miglitol) are used to manage postprandial hyperglycemia in diabetes by slowing carbohydrate digestion[6][10]. Deficiencies or dysfunctions of these enzymes can result in malabsorption and gastrointestinal symptoms (such as in lactose intolerance or some forms of congenital disaccharidase deficiency)[7].
Competitive inhibition of alpha-glucosidases; Inhibition of intestinal disaccharidases
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbohydrate digestion enzyme.